Screener
Indivior Pharmaceuticals, Inc. INDV Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $305M-31.5% | $222M-56.5% | $175M-53.0% | $195M-38.9% | $445M+54.5% | ||
| $273M+5.4% | $271M+12.9% | $273M+12.3% | $253M-0.4% | $259M+2,978% | ||
| $149M+14,800% | $2M-88.2% | $1M-91.7% | $2M-80.0% | $1M-83.3% | ||
| $800M-13.2% | $725M-23.8% | $667M-24.5% | $652M-21.2% | $922M— | ||
| $175M+41.1% | $162M+38.5% | $157M+51.0% | $144M+44.0% | $124M— | ||
| $2M0.0% | $2M-71.4% | $2M-71.4% | $2M-66.7% | $2M— | ||
| $1.33B-5.9% | $1.23B-15.1% | $1.2B-12.9% | $1.2B-8.7% | $1.42B— | ||
| $181M+341% | $30M-40.0% | $35M-23.9% | $48M-23.8% | $41M— | ||
| $488M+2,611% | $0-100% | $0-100% | $29M+61.1% | $18M— | ||
| $1.3B+34.8% | $868M-17.8% | $779M-22.5% | $914M-1.1% | $965M— | ||
| $0-100% | $487M+58.1% | $486M+56.3% | $290M-7.9% | $304M— | ||
| $1.39B-14.2% | $1.44B-15.7% | $1.34B-19.2% | $1.3B-21.3% | $1.62B— | ||
| $0-100% | $0-100% | $0-100% | $62M0.0% | $62M— | ||
| -$197M+43.1% | -$334M+13.9% | -$280M+31.0% | -$243M+45.1% | -$346M— | ||
| -$60M+71.0% | -$208M+19.1% | -$144M+49.5% | -$98M+70.9% | -$207M+33.2% | ||
| $1.33B-5.9% | $1.23B-15.1% | $1.2B-12.9% | $1.2B-8.7% | $1.42B— |
FAQ
- What are Indivior Pharmaceuticals, Inc.'s total assets?
- Indivior Pharmaceuticals, Inc. (INDV) holds $1.3B in total assets, down 5.9% year over year.
- How much debt does Indivior Pharmaceuticals, Inc. have?
- Indivior Pharmaceuticals, Inc. carries $501.0M in total debt against -$60.0M of shareholders' equity, a debt-to-equity ratio of -8.35.
- How much cash does Indivior Pharmaceuticals, Inc. have?
- Indivior Pharmaceuticals, Inc. holds $305.0M in cash and equivalents.
- Can Indivior Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 0.61 — current liabilities exceed current assets.
- Where does Indivior Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Indivior Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
